Ewing Sarcoma Treatment
Chemotherapy is usually the first treatment because the cancer often spreads microscopically to other parts of the body.
UT MD Anderson offers a comprehensive, multimodal approach to Ewing sarcoma, combining state‑of‑the‑art chemotherapy, targeted agents, surgery, conventional and proton radiation, and cutting‑edge clinical trials to improve outcomes and preserve function.
Early systemic therapy is essential in Ewing sarcoma to eliminate micrometastatic disease and improve long‑term survival while allowing definitive local control with surgery or radiation.
Bizonyítékszint: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Kapcsolódó jelek
- First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine—A Systematic Review
- Leiomyosarcoma
- Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
- Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
- Immunotherapy-based salvage therapy in advanced soft tissue sarcoma after first-line chemotherapy: a retrospective single-center analysis with emphasis on undifferentiated pleomorphic sarcoma